Anove-logoAnove-logoExplAIn
KaartenAI-koplopers
Terug naar directory

ChestEye Quality

door Oxipit

AI Application
Laag vertrouwen

ChestEye Quality is quality-assurance software for chest X-rays, used in radiology departments to catch findings that a radiologist's final report missed. Oxipit now markets it as 'Quality' within its CXR Suite; in its EUDAMED registration it is one of four functions of the ChestEye device, described as identifying potential reporting errors made by radiologists. The vendor says it analyses the final report together with the image, using a deep neural network on the X-ray, and flags discrepancies in near-real time; it can also audit large image archives retrospectively. Oxipit says a second human radiologist first reviews the flags, and only confirmed suspicions go to the reporting radiologist by email, with a heat map marking the area, for another look; the hospital can assign one of its own radiologists to that review. Oxipit says ChestEye is usually installed on the hospital's premises, with cloud deployment possible, and works on anonymised data; it names no hosting provider. Oxipit has been part of Sectra since 2026.

Bezoek website

Transparantiescore

Gewogen over vier pijlers · bijgewerkt October 20, 2026

Totaalscore
33% gewogen
ABCDF
Model
—
Nog niet beoordeeld
Infrastructuur
—
Nog niet beoordeeld

Functionaliteiten

Missed Finding Detection
Report Image Discrepancy Check
Retrospective Quality Audit
Radiologist Notification

Leveranciersinformatie

Volledige informatie over de leverancier/provider van deze AI-applicatie

OxipitBekijk alle producten →
Sectra Lithuania, UAB(Handelsnaam: Oxipit (part of Sectra))
Contactinformatie
oxipit.ai
info@oxipit.ai
Geregistreerd adres
Saulėtekio al. 15-1, Vilnius, Vilnius County, LT-10224, LT

Leveranciersinformatie volgens de EU AI Act

Verificatiestatus:
Unverified
(Laatst geverifieerd: October 20, 2026)
Sectra Lithuania, UAB(Handelsnaam: Oxipit (part of Sectra))
Saulėtekio al. 15-1, Vilnius, Vilnius County, LT-10224, LT
info@oxipit.ai
Nalevingsdocumenten
CE-markering: Certified
Aangemelde instantie: TÜV Rheinland LGA Products GmbH(Cert.: HZ 1550682-1)
Oxipit says ChestLink reports autonomously only on studies where it is highly confident there are no abnormalities, leaves any study with 'the slightest suspicion' to the radiologist, and recommends retrospective analysis and supervised operation before autonomous reporting (https://oxipit.ai/article/autonomous-ai-medical-imaging-understanding-chestlink/, 5 Apr 2022, read 2026-10-20). In the Finnish primary-care study it cites, ChestLink identified 36.4% of studies without significant findings at 99.8% sensitivity, with nine false negatives (slightly enlarged heart, slightly increased opacification, a small pleural effusion) among 9,579 cases (https://oxipit.ai/products/chestlink/, read 2026-10-20). The vendor refers users to the user guide for indications, contraindications and warnings; it is not public (https://oxipit.ai/regulatory-compliance-and-certifications/, read 2026-10-20).
Naleving & risico

Krijg inzicht in risico's door beoordelingen uit te voeren op deze AI-applicatie.

Werk je bij Oxipit? Claim deze vermelding om de gegevens te corrigeren of aan te vullen.

Toegevoegd: October 20, 2026
Bijgewerkt: October 20, 2026

Klaar om AI-applicaties te beheren?

Volg, beoordeel en beheer je AI-applicaties met Anove.

Anove-logoAnove-logoAnove International B.V.

We helpen organisaties AI-applicaties op een verantwoorde manier te ontdekken en beheren. Uw betrouwbare bron voor AI-governance en compliance.

Snelle links

  • Directory bekijken
  • FAQ
  • AI-kaarten per sector
  • Inloggen

Bronnen

  • Documentatie
  • Status
  • Anove.ai

Voorwaarden

  • Privacybeleid
  • Algemene voorwaarden
  • Responsible disclosure
  • AI-juridische kennisgeving
  • Beveiligingsbeleid

© 2026 Anove International B.V. Alle rechten voorbehouden.